{"id":848143,"title":"Mammalian cell culture-based influenza vaccines: National Advisory Committee on Immunization Supplemental Statement, CCDR 46(10) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-02-05","captureTimestamp":"2026-02-05T17:27:46.964000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/national-advisory-committee-immunization-supplemental-statement.html","snippet":"National Advisory Committee on Immunization Supplemental Statement Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 46–10: Laboratory Biosafety Date published: October 1, 2020 ISSN: 1481-8531 Subscribe to CCDR Submit your manuscript…","rawSnapshotUrl":"/api/snapshots/raw/848143","browseUrl":"https://replay.healtharchive.ca/job-7/20260205172746/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-10-october-1-2020/national-advisory-committee-immunization-supplemental-statement.html#ha_snapshot=848143","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}